The "North America RNA Therapeutics Market, By Country, Competition, Forecast & Opportunities, 2019-2029F" report has been ...

Organizing in response to the COVID-19 pandemic, Verena is a founding member of TEXGHS ... scientists and clinicians ...

A new clinical study shows that an inhibitor of Fas ligand (FasL), also called CD95 ligand (CD95L), led to a faster recovery ...

The Africa Centres for Disease Control and Prevention has approved the first locally-made diagnostic test for mpox, as the agency aims to stem outbreaks of the lethal disease on the continent.

Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan, President and Representative Director: Daikichiro Kobayashi; hereinafter referred to as "Meiji Seika Pharma") today announced its investment ...

Analysts at StockNews.com started coverage on shares of Oragenics (NYSE:OGEN – Get Free Report) in a report issued on Tuesday. The firm set a “sell” rating on the stock. Oragenics Trading Down 6.6 % ...

BioNTech, the German developer of a widely used mRNA vaccine for the coronavirus, agreed to pay US$800 million ... in ...

Intermittent fasting probably isn’t the health hack you hoped it would be. More studies suggest the tactic can help you lose ...

Extreme tiredness, brain fog and problems with taste or smell are well-known symptoms of long COVID. Could NE Ohio dish out ...

Request To Download Free Sample of This Strategic Report @ The publisher has been closely monitoring the various markets in Saudi Arabia Peptide Therapeutics Market. This report provides a ...

Nov 13 (Reuters) - The U.S. Food and Drug Administration approved PTC Therapeutics' (PTCT.O), opens new tab gene therapy to ...

Fintel reports that on November 12, 2024, UBS initiated coverage of Altimmune (NasdaqGM:ALT) with a Buy recommendation.